Lynne Bingle

The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms

Lynne Bingle, Colin D. Bingle · Oncogene · 2002 · 232 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung

Lynne Bingle, Simon S. Cross, A.S. High et al. · Respiratory Research · 2006 · 202 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Macrophages promote angiogenesis in human breast tumour spheroids in vivo

Lynne Bingle, Claire E. Lewis, Kevin P. Corke et al. · British Journal of Cancer · 2005 · 186 citations · Full text

Medicine, Immunology, Oncology +16

Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor

Jon R. Ward, Lynne Bingle, Heather M. Judge et al. · Thrombosis and Haemostasis · 2005 · 135 citations

Life Sciences, Immunology, Pathobiology +17

<i>In vitro</i> study of HIF‐1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI‐3K/Akt and MEK1/ERK pathways

Yonghong Shi, Yuxiang Wang, Lynne Bingle et al. · The Journal of Pathology · 2005 · 105 citations

Medicine, Cancer Biology, Oncology +17